Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
October-2020 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2020 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action

  • Authors:
    • Mengyi Jiang
    • Xuemei Wang
    • Pin Wang
    • Wei Peng
    • Bo Zhang
    • Ling Guo
  • View Affiliations / Copyright

    Affiliations: Department of Prosthodontics, Hospital of Stomatology Affiliated to Southwest Medical University, Luzhou, Sichuan 646000, P.R. China
    Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3255-3262
    |
    Published online on: August 7, 2020
       https://doi.org/10.3892/mmr.2020.11422
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The occurrence and development of hyperglycemia‑induced inflammation is associated with increased expression of receptor for advanced glycation end products (RAGE) and inflammatory factors, including IL‑1β, TNF‑α and IL‑6. Previous studies have reported that the nucleotide‑binding oligomerization domain‑like receptor protein 3 (NLRP3) inflammasome interacts with thioredoxin‑interacting protein (TXNIP) and serves a crucial role in inflammation. FPS‑ZM1 has been identified as target inhibitor of RAGE and has been shown to exert an anti‑inflammatory effect in vitro. However, the underlying mechanism by which FPS‑ZM1 impacts high glucose (HG)‑induced inflammation in bone marrow mesenchymal stem cells (BMSCs) remains unclear. The present study explored the regulatory effect of FPS‑ZM1 on HG‑induced inflammation in BMSCs. Furthermore, the role of the TXNIP/NLRP3 inflammasome signaling pathway in the regulatory effects of FPS‑ZM1 on HG‑induced inflammation was studied. Cell viability was determined using Cell Counting Kit‑8 and western blotting was used to assess the protein expression levels of RAGE. ELISA was used to determine the levels of inflammatory markers. Reverse transcription‑quantitative PCR and western blotting were used to measure the mRNA and protein expression levels of TXNIP, caspase‑1, thioredoxin (TRX), NLRP3 and apoptosis‑related speck‑like protein containing CARD (ASC). The results revealed that in BMSCs, RAGE expression was stimulated by HG, an effect which was reversed by treatment with FPS‑ZM1. In addition, HG activated inflammatory factors, such as TNF‑α, IL‑1β and IL‑6; however, their levels were suppressed when cells were treated with FPS‑ZM1 or the TXNIP/NLRP3 pathway inhibitor, resveratrol (Res). Furthermore, FPS‑ZM1 inhibited the mRNA and protein expression levels of TXNIP, caspase‑1, NLRP3 and ASC, and promoted TRX expression, which was consistent with the effects of Res. These findings indicated that FPS‑ZM1 may attenuate HG‑induced inflammation in BMSCs. Furthermore, the TXNIP/NLRP3 inflammasome signaling pathway mediated the molecular mechanism underlying this effect.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Shi Y and Hu FB: The global implications of diabetes and cancer. Lancet. 383:3255–1948. 2014. View Article : Google Scholar

2 

Yamamoto Y and Yamamoto H: RAGE-Mediated Inflammation, type 2 diabetes, and diabetic vascular complication. Front Endocrinol (Lausanne). 4:1052013. View Article : Google Scholar : PubMed/NCBI

3 

Rübsam A, Parikh S and Fort PE: Role of Inflammation in diabetic retinopathy. Int J Mol Sci. 19:9422018. View Article : Google Scholar

4 

Yuan Y, Sun H and Sun Z: Advanced glycation end products (AGEs) increase renal lipid accumulation: A pathogenic factor of diabetic nephropathy (DN). Lipids Health Dis. 16:1262017. View Article : Google Scholar : PubMed/NCBI

5 

Shi L, Yu X, Yang H and Wu X: Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. PLoS One. 8:e667812013. View Article : Google Scholar : PubMed/NCBI

6 

Meloche J, Paulin R, Roy M, Agharazii M and Bonnet S: Activation of RAGE/STAT3 axis by advanced glycation endproducts in vascular remodeling diseases. Circulation. 122 (Suppl 21):S159692010.

7 

Sanajou D, Haghjo AG, Argani H and Aslani S: AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. Eur J Pharmacol. 833:158–164. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Sanajou D, Ghorbani Haghjo A, Argani H, Roshangar L, Rashtchizadeh N, Ahmad SNS, Ashrafi-Jigheh Z and Bahrambeigi S: Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat. Eur J Pharmacol. 842:40–48. 2019. View Article : Google Scholar : PubMed/NCBI

9 

Zhan D, Guo L and Zheng L: Inhibition of the receptor for advanced glycation promotes proliferation and repair of human periodontal ligament fibroblasts in response to high glucose via the NF-kappa B signaling pathway. Arch Oral Biol. 87:86–93. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Huang J, Xiong T, Zhang Z, Tan Y and Guo L: Inhibition of the receptor for advanced glycation inhibits lipopolysaccharide-mediated High mobility group protein B1 and Interleukin-6 synthesis in human gingival fibroblasts through the NF-κB signaling pathway. Arch Oral Biol. 105:81–87. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Graves DT, Ding Z and Yang Y: The impact of diabetes on periodontal diseases. Periodontol. 82:214–224. 2020. View Article : Google Scholar

12 

Almajwal AM, Alam I, Abulmeaty M, Razak S, Pawelec G and Alam W: Intake of dietary advanced glycation end products influences inflammatory markers, Immune phenotypes, and antiradical capacity of healthy elderly in a little-studied population. Food Sci Nutr. 8:1046–1057. 2020. View Article : Google Scholar : PubMed/NCBI

13 

Yao D, Wang S, Wang M and Lu W: Renoprotection of dapagliflozin in human renal proximal tubular cells via the inhibition of the high mobility group box 1receptor for advanced glycation end productsnuclear factor-κB signaling pathway. Mol Med Rep. 18:3625–3630. 2018.PubMed/NCBI

14 

Chang PC, Chien LY, Yeo JF, Wang YP, Chung MC, Chong LY, Kuo MY, Chen CH, Chiang HC, Ng BN, et al: Progression of periodontal destruction and the roles of advanced glycation end products in experimental diabetes. J Periodontol. 84:379–388. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Bartold PM and Van Dyke TE: Periodontitis: A host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol. 62:203–217. 2013. View Article : Google Scholar

16 

Al-Sowygh ZH, Ghani SMA, Sergis K, Vohra F and Akram Z: Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control. Clin Implant Dent Relat Res. 20:345–351. 2018. View Article : Google Scholar : PubMed/NCBI

17 

Dey D, Jingar P, Agrawal S, Shrivastava V, Bhattacharya A, Manhas J, Garg B, Ansari MT, Mridha AR, Sreenivas V, et al: Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts. J Ethnopharmacol. 248:1123292020. View Article : Google Scholar : PubMed/NCBI

18 

Dhanasekaran M, Indumathi S, Rajkumar JS and Sudarsanam D: Effect of high glucose on extensive culturing of mesenchymal stem cells derived from subcutaneous fat, omentum fat and bone marrow. Cell Biochem Funct. 31:20–29. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Nonaka K, Kajiura Y, Bando M, Sakamoto E, Inagaki Y, Lew JH, Naruishi K, Ikuta T, Yoshida K, Kobayashi T, et al: Advanced glycation end-products increase IL-6 and ICAM-1 expression via RAGE, MAPK and NF-κB pathways in human gingival fibroblasts. J Periodontal Res. 53:334–344. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Thielen L and Shalev A: Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP. Curr Opin Endocrinol Diabetes Obes. 25:75–80. 2018. View Article : Google Scholar : PubMed/NCBI

21 

Gouravani M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N and Rezaei N: The NLRP3 inflammasome: A therapeutic target for inflammation-associated cancers. Expert Rev Clin Immunol. 16:175–187. 2020. View Article : Google Scholar : PubMed/NCBI

22 

Feng H, Gu J, Gou F, Huang W, Gao C, Chen G, Long Y, Zhou X, Yang M, Liu S, et al: High Glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells. J Diabetes Res. 2016:1–11. 2016. View Article : Google Scholar

23 

An N, Gao Y, Si Z, Zhang H, Wang L, Tian C, Yuan M, Yang X, Li X, Shang H, et al: Regulatory mechanisms of the NLRP3 inflammasome, a novel immune-inflammatory marker in cardiovascular diseases. Front Immunol. 10:15922019. View Article : Google Scholar : PubMed/NCBI

24 

Matsui T, Nakamura N, Ojima A, Nishino Y and Yamagishi SI: Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta. Nutr Metab Cardiovasc Dis. 26:797–807. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, Rainone V, Nemni R, Mancuso R and Clerici M: The NLRP3 and NLRP1 inflammasomes are activated in Alzheimers disease. Mol Neurodegener. 11:232016. View Article : Google Scholar : PubMed/NCBI

26 

Zhao LR, Xing RL, Wang PM, Zhang NS, Yin SJ, Li XC and Zhang L: NLRP1 and NLRP3 inflammasomes mediate LPS/ATP-induced pyroptosis in knee osteoarthritis. Mol Med Rep. 17:5463–5469. 2018.PubMed/NCBI

27 

Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 12:408–415. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Bharti V, Tan H, Zhou H and Wang JF: Txnip mediates glucocorticoid-activated NLRP3 inflammatory signaling in mouse microglia. Neurochem Int. 131:1045642019. View Article : Google Scholar : PubMed/NCBI

29 

Omar DF, Kamal MM, El-Hefnawy MH and El-Mesallamy HO: Serum Vitamin D and its upregulated protein, thioredoxin interacting protein, are associated with beta-cell dysfunction in adult patients with type 1 and type 2 diabetes. Can J Diabetes. 42:588–594. 2018. View Article : Google Scholar : PubMed/NCBI

30 

Gateva AT, Assyov YS, Velikova T and Kamenov ZA: Higher levels of thioredoxin interacting protein (TXNIP) in patients with prediabetes compared to obese normoglycemic subjects. Diabetes Metabolic Syndrome. 13:734–737. 2019. View Article : Google Scholar : PubMed/NCBI

31 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Chiu HC, Fu MM, Yang TS, Fu E, Chiang CY, Tu HP, Chin YT, Lin FG and Shih KC: Effect of high glucose, Porphyromonas gingivalis lipopolysaccharide and advanced glycation endproducts on production of interleukin-6/-8 by gingival fibroblasts. J Periodontal Res. 52:268–276. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Lalla E, Lamster IB, Stern DM and Schmidt AM: Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: Mechanisms and insights into therapeutic modalities. Ann Periodontol. 6:113–118. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Daniele G, Guardado Mendoza R, Winnier D, Fiorentino TV, Pengou Z, Cornell J, Andreozzi F, Jenkinson C, Cersosimo E, Federici M, et al: The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol. 51:123–131. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Han Y, Xu X, Tang C, Gao P, Chen X, Xiong X, Yang M, Yang S, Zhu X, Yuan S, et al: Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol. 16:32–46. 2018. View Article : Google Scholar : PubMed/NCBI

36 

Taylor JJ, Preshaw PM and Lalla E: A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol. 40 (4 Suppl):S113–S134. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, et al: Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 138:984–1010. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Zheng DH, Han ZQ, Wang XX, Ma D and Zhang J: Erythropoietin attenuates high glucose-induced oxidative stress and inhibition of osteogenic differentiation in periodontal ligament stem cell (PDLSCs). Chem Biol Interact. 305:40–47. 2019. View Article : Google Scholar : PubMed/NCBI

39 

Kang K, Chuai JB, Xie BD, Li JZ, Qu H, Wu H, Fang SH, Cui JJ, Xiu LL, Han JC, et al: Mesenchymal stromal cells from patients with cyanotic congenital heart disease are optimal candidate for cardiac tissue engineering. Biomaterials. 230:1195742020. View Article : Google Scholar : PubMed/NCBI

40 

Dong H, Wang Z, Chen Y and Li Y: Protective effects of bone Marrow-derived mesenchymal stem cells on insulin secretion and inflammation in the treatment of severe acute pancreatitis in rats. Transplant Proc. 52:333–344. 2020. View Article : Google Scholar : PubMed/NCBI

41 

Li H, Zhou HL, Guo F, Wang Q and Li W: The effects of 25-hydroxyvitamin D3 on the activation of NLRP3 inflammasome and inflammatory response of bone marrow mesenchymal stem cells from the diabetic rats. J Pract Stomatol. 34:11–15. 2018.

42 

Liao F, Liu Y, Liu HH, Hu J, Zhao S and Yang SM: Effect of Angelica sinensis polysaccharide on the osteogenic differentiation of bone marrow mesenchymal stem cells of rats with high glucose levels. Hua Xi Kou Qiang Yi Xue Za Zhi. 37:193–199. 2019.(In Chinese). PubMed/NCBI

43 

Li H, Wang D, Chen Y and Yang M: β-Caryophyllene inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells. Int Immunopharmacol. 84:1065562020. View Article : Google Scholar : PubMed/NCBI

44 

Soydas T, Yaprak Sarac E, Cinar S, Dogan S, Solakoglu S, Tuncdemir M and Kanigur Sultuybek G: The protective effects of metformin in an in vitro model of aging 3T3 fibroblast under the high glucose conditions. J Physiol Biochem. 74:273–281. 2018. View Article : Google Scholar : PubMed/NCBI

45 

Wu J, Lu K, Zhu M, Xie X, Ding Y, Shao X, Chen Y, Liu J, Xu M, Xu Y, et al: miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5. Biochem Biophys Res Commun. 521:984–990. 2020. View Article : Google Scholar : PubMed/NCBI

46 

Wang Z, Maruyama K, Sakisaka Y, Suzuki S, Tada H, Suto M, Saito M, Yamada S and Nemoto E: Cyclic stretch force induces periodontal ligament cells to secrete exosomes that suppress IL-1β production through the inhibition of the NF-κB signaling pathway in macrophages. Front Immunol. 10:13102019. View Article : Google Scholar : PubMed/NCBI

47 

Yang L, Wu L, Zhang X, Hu Y, Fan Y and Ma J: 1,25(OH)2D3/VDR attenuates high glucoseinduced epithelialmesenchymal transition in human peritoneal mesothelial cells via the TGFβ/Smad3 pathway. Mol Med Rep. 15:2273–2279. 2017. View Article : Google Scholar : PubMed/NCBI

48 

Dong F, Dong S, Liang Y, Wang K, Qin Y and Zhao X: miR-20b inhibits the senescence of human umbilical vein endothelial cells through regulating the Wnt/β-catenin pathway via the TXNIP/NLRP3 axis. Int J Mol Med. 45:847–857. 2020.PubMed/NCBI

49 

Lu WL, Song DZ, Yue JL, Wang TT, Zhou XD, Zhang P, Zhang L and Huang DM: NLRP3 inflammasome may regulate inflammatory response of human periodontal ligament fibroblasts in an apoptosis-associated speck-like protein containing a CARD (ASC)-dependent manner. Int Endod J. 50:967–975. 2017. View Article : Google Scholar : PubMed/NCBI

50 

Bui FQ, Johnson L, Roberts J, Hung SC, Lee J, Atanasova KR, Huang PR, Yilmaz Ö and Ojcius DM: Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1β and the danger signals ASC and HMGB1. Cell Microbiol. 18:970–981. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Szpigel A, Hainault I, Carlier A, Venteclef N, Batto AF, Hajduch E, Bernard C, Ktorza A, Gautier JF, Ferré P, et al: Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes. Diabetologia. 61:399–412. 2018. View Article : Google Scholar : PubMed/NCBI

52 

Lu L, Lu Q, Chen W, Li J, Li C and Zheng Z: Vitamin D3 Protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS/TXNIP/NLRP3 inflammasome pathway. J Diabetes Res. 2018:81935232018. View Article : Google Scholar : PubMed/NCBI

53 

Yi X, Zhang L, Lu W, Tan X, Yue J, Wang P, Xu W, Ye L and Huang D: The effect of NLRP inflammasome on the regulation of AGEs-induced inflammatory response in human periodontal ligament cells. J Periodontal Res. 54:681–689. 2019. View Article : Google Scholar : PubMed/NCBI

54 

Bedarida T, Baron S, Vibert F, Ayer A, Henrion D, Thioulouse E, Marchiol C, Beaudeux JL, Cottart CH and Nivet-Antoine V: Resveratrol decreases TXNIP mRNA and protein nuclear expressions with an arterial function improvement in old mice. J Gerontol A Biol Sci Med Sci. 71:720–729. 2016. View Article : Google Scholar : PubMed/NCBI

55 

Choe D, Palsson B and Cho BK: STATR: A simple analysis pipeline of Ribo-Seq in bacteria. J Microbiol. 58:217–226. 2020. View Article : Google Scholar : PubMed/NCBI

56 

Jeong Y, Kim JN, Kim MW, Bucca G, Cho S, Yoon YJ, Kim BG, Roe JH, Kim SC, Smith CP, et al: The dynamic transcriptional and translational landscape of the model antibiotic producer Streptomyces coelicolor. Nat Commun. 7:116052016. View Article : Google Scholar : PubMed/NCBI

57 

Liu Y, Beyer A and Aebersold R: On the dependency of cellular protein levels on mRNA abundance. Cell. 165:535–550. 2016. View Article : Google Scholar : PubMed/NCBI

58 

Koussounadis A, Langdon SP, Um IH, Harrison DJ and Smith VA: Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system. Sci Rep. 5:107752015. View Article : Google Scholar : PubMed/NCBI

59 

Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W and Selbach M: Global quantification of mammalian gene expression control. Nature. 473:337–342. 2011. View Article : Google Scholar : PubMed/NCBI

60 

Surkova S, Sokolkova A, Kozlov K, Nuzhdin SV and Samsonova M: Quantitative analysis reveals genotype- and domain-specific differences between mRNA and protein expression of segmentation genes in Drosophila. Dev Biol. 448:48–58. 2019. View Article : Google Scholar : PubMed/NCBI

61 

Wu X, Zhao W, Cui Q and Zhou Y: Computational screening of potential regulators for mRNA-protein expression level discrepancy. Biochem Biophys Res Commun. 523:196–201. 2020. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jiang M, Wang X, Wang P, Peng W, Zhang B and Guo L: Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action. Mol Med Rep 22: 3255-3262, 2020.
APA
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., & Guo, L. (2020). Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action. Molecular Medicine Reports, 22, 3255-3262. https://doi.org/10.3892/mmr.2020.11422
MLA
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., Guo, L."Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action". Molecular Medicine Reports 22.4 (2020): 3255-3262.
Chicago
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., Guo, L."Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action". Molecular Medicine Reports 22, no. 4 (2020): 3255-3262. https://doi.org/10.3892/mmr.2020.11422
Copy and paste a formatted citation
x
Spandidos Publications style
Jiang M, Wang X, Wang P, Peng W, Zhang B and Guo L: Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action. Mol Med Rep 22: 3255-3262, 2020.
APA
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., & Guo, L. (2020). Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action. Molecular Medicine Reports, 22, 3255-3262. https://doi.org/10.3892/mmr.2020.11422
MLA
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., Guo, L."Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action". Molecular Medicine Reports 22.4 (2020): 3255-3262.
Chicago
Jiang, M., Wang, X., Wang, P., Peng, W., Zhang, B., Guo, L."Inhibitor of RAGE and glucose‑induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action". Molecular Medicine Reports 22, no. 4 (2020): 3255-3262. https://doi.org/10.3892/mmr.2020.11422
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team